SCOPUS 정보 검색 플랫폼

Cancer Immunology Immunotherapy

Volumn 49, Issue 8, 2000, Pages 410-416

CD40 activation enhances the magnitude of cellular immune responses against p53 but not the avidity of the effectors

(2) Erdile, L F a Smith, D a

a Aventis Pasteur / Virogenetics (United States)

Author keywords

CD40; Cellular immune response; P53

Indexed keywords

CD40 ANTIGEN; EPITOPE; GAMMA INTERFERON; LIPOPEPTIDE; MONOCLONAL ANTIBODY; PROTEIN P53; TUMOR ANTIGEN;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER IMMUNOTHERAPY; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; MOUSE; NONHUMAN; PRIORITY JOURNAL; TITRIMETRY;

EID: 0033807242 PISSN: 03407004 EISSN: None Source Type: Journal
DOI: 10.1007/s002620000135 Document Type: Article

Times cited : (7)

References (29)

1
- 0028036933
- Immunizing and curative potential of replicating and nonreplicating murine mammary adenocarcinoma cells engineered with interleukin (IL)-2, IL-4, IL-6, IL-7, IL-10, tumor necrosis factor α, granulocyte-macrophage colony-stimulating factor and γ-interferon gene or admixed with conventional adjuvants
- (1994) Cancer Res , vol.54 , pp. 6022
- Allione, A.¹ Consalvo, M.² Nanni, P.³ Lollini, P.L.⁴ Cavallo, F.⁵ Giovarelli, M.⁶ Forni, M.⁷ Gulino, A.⁸ Colombo, M.P.⁹ Dellabona, P.¹⁰ Hock, H.¹¹ Blankenstein, T.¹² Rosenthal, F.M.¹³ Gansbacher, B.¹⁴ Bosco, M.C.¹⁵ Musso, T.¹⁶ Gusella, L.¹⁷ Forni, G.¹⁸

2
- 0032482356
- Help for cytotoxic-T-cell responses is mediated by CD40 signalling
- (1998) Nature , vol.393 , pp. 478
- Bennett, S.R.M.¹ Carbone, F.R.² Karamalis, F.³ Flavell, R.A.⁴ Miller, J.F.A.P.⁵ Heath, W.R.⁶

3
- 0029812593
- Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
- (1996) J Exp Med , vol.184 , pp. 747
- Cella, M.¹ Scheidegger, D.² Palmer-Lehmann, K.³ Lane, P.⁴ Lanzavecchia, A.⁵ Alber, G.⁶

4
- 0029878034
- Induction of cytotoxic T lymphocytes and antitumor immunity with DNA vaccines expressing single T cell epitopes
- (1996) J Immunol , vol.156 , pp. 2369
- Ciernik, I.F.¹ Berzofsky, J.A.² Carbone, D.P.³

5
- 0024389666
- In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine
- (1989) Nature , vol.342 , pp. 561
- Deres, K.¹ Schild, H.² Weismuller, K.H.³ Jung, G.⁴ Rammensee, H.G.⁵

6
- 0032984496
- CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy
- (1999) Nat Med , vol.5 , pp. 774
- Diehl, L.¹ Den Boer, A.Th.² Schoenberger, S.P.³ Van der Voort, E.I.H.⁴ Schumacher, T.N.M.⁵ Melief, C.J.M.⁶ Offringa, R.⁷ Toes, R.E.M.⁸

7
- 0032896709
- CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help
- (1999) Nat Med , vol.5 , pp. 548
- French, R.R.¹ Chan, H.T.C.² Tutt, A.L.³ Glennie, M.J.⁴

8
- 0031905632
- Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas
- (1998) J Immunol , vol.160 , pp. 328
- Gnjatic, S.¹ Cai, Z.² Viguier, M.³ Chouaib, S.⁴ Guillet, J.-G.⁵ Choppin, J.⁶

9
- 0032213323
- CD40 ligand/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge
- (1998) J Immunol , vol.161 , pp. 4563
- Gurunathan, S.¹ Irvine, K.I.² Wu, C.-Y.³ Cohen, J.I.⁴ Thomas, E.⁵ Prussin, C.⁶ Restifo, N.⁷ Seder, R.A.⁸

10
- 0025894713
- p53 mutations in human cancers
- (1991) Science , vol.253 , pp. 49
- Hollstein, M.¹ Sidransky, D.² Vogelstein, B.³ Harris, C.C.⁴

11
- 0031986115
- The mode of presentation and route of administration is critical for the induction of immune responses to p53 and antitumor immunity
- (1998) Vaccine , vol.16 , pp. 208
- Hurpin, C.¹ Rotario, C.² Bisceglia, H.³ Chevalier, M.⁴ Tartaglia, J.⁵ Erdile, L.⁶

12
- 0024263475
- Cooperation between helper T cells and cytotoxic T lymphocyte precursors
- (1998) Ann NY Acad Sci , vol.532 , pp. 158
- Husmann, L.A.¹ Bevan, M.J.²

13
- 0025876591
- The p53 tumour suppressor gene
- (1991) Nature , vol.351 , pp. 453
- Levine, A.J.¹ Momand, J.² Finlay, C.A.³

14
- 0029911677
- Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines
- (1996) J Exp Med , vol.183 , pp. 1357
- Mayordomo, J.I.¹ Loftus, D.J.² Sakamoto, H.³ De Cesare, C.M.⁴ Appasamy, P.M.⁵ Lotze, M.T.⁶ Storkus, W.J.⁷ Appella, E.⁸ DeLeo, A.B.⁹

15
- 0028203254
- A mouse mutant p53 product recognized by CD4+ and CD8+ T cells
- (1994) Proc Natl Acad Sci USA , vol.91 , pp. 3171
- Noguchi, Y.¹ Chen, Y.T.² Old, L.J.³

16
- 17344386915
- Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses
- (1998) Vaccine , vol.16 , pp. 823
- Oseroff, C.¹ Sette, A.² Wentworth, P.³ Celis, E.⁴ Maewal, A.⁵ Dahlberg, C.⁶ Fikes, J.⁷ Kubo, R.T.⁸ Chesnut, R.W.⁹ Grey, H.M.¹⁰ Alexander, J.¹¹

17
- 0031852722
- Gp100/pmel 17 is a murine tumor rejection antigen: Induction of self-reactive tumoricidal T cells using high-affinity altered peptide ligand
- (1998) J Exp Med , vol.188 , pp. 277
- Overwijk, W.W.¹ Tsung, A.² Irvine, K.R.³ Parkhurst, M.R.⁴ Goletz, T.J.⁵ Tsung, K.⁶ Carroll, M.W.⁷ Liu, C.⁸ Moss, B.⁹ Rosenberg, S.A.¹⁰ Restifo, N.P.¹¹

18
- 0032482337
- + T-helper and a T-killer cell
- (1998) Nature , vol.393 , pp. 474
- Ridge, J.P.¹ Di Rosa, F.² Matzinger, P.³

19
- 1842339552
- Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide
- (1996) Proc Natl Acad Sci USA , vol.93 , pp. 14704
- Ropke, M.¹ Hald, J.² Guldberg, P.³ Zeuthe, J.⁴ Norgaard, L.⁵ Fugger, L.⁶ Svejgaard, A.⁷ Van der Burg, S.⁸ Nijman, H.W.⁹ Melief, C.J.¹⁰ Claesson, M.H.¹¹

20
- 0031890206
- Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
- (1998) Nat Med , vol.4 , pp. 321
- Rosenberg, S.A.¹ Yang, J.C.² Schwartzentruber, D.J.³ Hwu, P.⁴ Marincola, F.M.⁵ Topalian, S.L.⁶ Restifo, N.P.⁷ Dudley, M.E.⁸ Schwarz, S.L.⁹ Spiess, P.J.¹⁰ Wunderlich, J.R.¹¹ Parkhurst, M.R.¹² Kawakami, Y.¹³ Seipp, C.A.¹⁴ Einhorn, J.H.¹⁵ White, D.E.¹⁶

21
- 0029978501
- p53 as a target for cancer vaccines: Recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge
- (1996) Proc Natl Acad Sci USA , vol.93 , pp. 4781
- Roth, J.¹ Dittmer, D.² Rea, D.³ Tartaglia, J.⁴ Paoletti, E.⁵ Levine, A.J.⁶

22
- 0032482474
- T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions
- (1998) Nature , vol.393 , pp. 480
- Schoenberger, S.P.¹ Toes, R.E.M.² Van der Voort, E.I.H.³ Offringa, R.⁴ Melief, C.J.M.⁵

23
- 0032984347
- + T-cell tolerance to T-cell priming through in vivo ligation of CD40
- (1999) Nat Med , vol.5 , pp. 780
- Sotomayor, E.M.¹ Borrello, I.² Tubb, E.³ Rattis, F.-M.⁴ Bien, H.⁵ Lu, Z.⁶ Fein, S.⁷ Schoenberger, S.⁸ Levitsky, H.I.⁹

24
- 0030892137
- Tolerance to p53 by A2.1-restricted cytotoxic T lymphocytes
- (1997) J Exp Med , vol.185 , pp. 833
- Theobald, M.¹ Biggs, J.² Hernandez, J.³ Lustgarten, J.⁴ Labadie, C.⁵ Sherman, L.A.⁶

25
- 0032555911
- The sequence alteration associated with a mutational hotspot in p53 protects cells from lysis by cytotoxic T lymphocytes specific for a flanking peptide epitope
- (1998) J Exp Med , vol.188 , pp. 1017
- Theobald, M.¹ Ruppert, T.² Kuckelhorn, U.³ Hernandez, J.⁴ Haussler, A.⁵ Ferreira, E.A.⁶ Liewer, U.⁷ Biggs, J.⁸ Levine, A.J.⁹ Huber, C.¹⁰ Koszinowski, U.H.¹¹ Kloetzel, P.-M.¹² Sherman, L.A.¹³

26
- 0029042336
- Generation of human ctotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine
- (1995) J Natl Cancer Inst , vol.87 , pp. 982
- Tsang, K.Y.¹ Zaremba, S.² Nieroda, C.A.³ Zhu, M.Z.⁴ Hamilton, J.M.⁵ Schlom, J.⁶

27
- 1842370254
- Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or 'sell' antigen induce antitumor immunity in vivo
- (1997) Eur J Immunol , vol.27 , pp. 2702
- Tuting, T.¹ DeLeo, A.B.² Lotze, M.T.³ Storkus, W.J.⁴

28
- 0030769148
- Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes
- (1997) J Exp Med , vol.186 , pp. 695
- Vierboom, M.P.M.¹ Nijman, H.W.² Offringa, R.³ Van der Voort, E.I.H.⁴ Van Hall, T.⁵ Van Den Broek, L.⁶ Fleuren, G.J.⁷ Kenemans, P.⁸ Kast, W.M.⁹ Melief, C.J.M.¹⁰

29
- 0033556322
- High avidity CTLs for two self-antigens demonstrate superior in vitro and in vivo antitumor efficacy
- (1999) J Immunol , vol.162 , pp. 989
- Zeh III, H.J.¹ Perry-Lalley, D.² Dudley, M.E.³ Rosenberg, S.A.⁴ Yang, J.C.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.